Literature DB >> 29174443

Persistent Dentoalveolar Pain Disorder: A Comprehensive Review.

Alberto Malacarne1, Egilius L H Spierings2, Chao Lu2, George E Maloney2.   

Abstract

INTRODUCTION: Persistent dentoalveolar pain of idiopathic origin represents a diagnostic challenge for the dentist and physician alike. Disagreement on taxonomy and diagnostic criteria presents a significant limit to the advancement of research in the field. Patients struggle with a lack of knowledge by dental and medical professionals, diagnostic delays, and unnecessary treatments.
METHODS: A PubMed search was performed as of January 1, 2017 by using the terms atypical odontalgia, phantom tooth pain, persistent idiopathic facial pain, painful posttraumatic trigeminal neuropathy, idiopathic toothache, persistent dentoalveolar pain disorder, nonodontogenic tooth pain, and continuous neuropathic orofacial pain. Three hundred forty-five abstracts were screened, and 128 articles that were pertinent to the topic went through full-text reading.
RESULTS: Case reports and narrative reviews constitute the majority of available literature. Several retrospective case-control studies investigated the clinical characteristics, pathophysiology, and diagnostic processes. Treatment strategies were evaluated in only 7 open-label and 2 randomized controlled trials.
CONCLUSIONS: Persistent dentoalveolar pain disorder is likely neuropathic in origin, but pathophysiological mechanisms to explain the onset and persistence of the pain are still far from understood. A correct diagnosis should be established before treatments are performed. Researchers should reach an agreement on the diagnostic criteria to enable a coherent research path to better understand the condition and reduce patient suffering.
Copyright © 2017 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical odontalgia; idiopathic toothache; nonodontogenic toothache; painful posttraumatic trigeminal neuropathy; persistent dentoalveolar pain disorder

Mesh:

Year:  2017        PMID: 29174443     DOI: 10.1016/j.joen.2017.09.009

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  6 in total

1.  3-year Outcome of Patients with Persistent Pain after Root Canal Treatment: The National Dental Practice-Based Research Network.

Authors:  Iryna H Daline; Donald R Nixdorf; Alan S Law; Roberta Pileggi
Journal:  J Endod       Date:  2020-03-11       Impact factor: 4.171

Review 2.  Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition.

Authors:  Alberto Herrero Babiloni; Donald R Nixdorf; Estephan J Moana-Filho
Journal:  Oral Dis       Date:  2019-12-17       Impact factor: 3.511

3.  OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients.

Authors:  Rafael García-Sáez; Álvaro Gutiérrez-Viedma; Nuria González-García; Víctor Gómez-Mayordomo; Jesús Porta-Etessam; María-Luz Cuadrado
Journal:  J Pain Res       Date:  2018-08-23       Impact factor: 3.133

4.  Patients with persistent idiopathic dentoalveolar pain in dental practice.

Authors:  Frank Sanner; David Sonntag; Norbert Hambrock; Matthias Zehnder
Journal:  Int Endod J       Date:  2021-12-02       Impact factor: 5.165

5.  Atypical odontalgia and trigeminal neuralgia: psychological, behavioral and psychopharmacological approach in a dental clinic - an overview of pathologies related to the challenging differential diagnosis in orofacial pain.

Authors:  Riccardo Tizzoni; Marta Tizzoni; Carlo Alfredo Clerici
Journal:  F1000Res       Date:  2021-04-23

6.  Jaw Exercise Therapy and Psychoeducation to Reduce Oral Parafunctional Activities for the Management of Persistent Dentoalveolar Pain.

Authors:  Izumi Makino; Young-Chang Arai; Shuichi Aono; Masayuki Inoue; Hiroki Sakurai; Yusuke Ohmichi; Kazuhiro Shimo; Makoto Nishihara; Jun Sato; Noboru Hatakeyama; Takako Matsubara; Tatsunori Ikemoto; Takahiro Ushida
Journal:  Pain Res Manag       Date:  2018-09-12       Impact factor: 3.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.